Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Morlock

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
American Journal of Ophthalmology|March 26, 2017
Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and ValidationRobert Morlock, R J Wirth, Steven R Tally, et al.
CNS Neuroscience & Therapeutics|February 21, 2009
Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorderDouglas E Feltner, Jane Harness, Jerri Brock, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 10, 2018
Scale development with small samples: a new application of longitudinal item response theoryCarrie R Houts, Robert Morlock, Steven I Blum, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 23, 2021
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinomaFlorian Lordick, Salah-Eddin Al-Batran, Arijit Ganguli, et al.
Cancer Management and Research|May 12, 2017
Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experimentJuan Marcos González, Sarika Ogale, Robert Morlock, et al.
Journal of Managed Care & Specialty Pharmacy|June 3, 2025
Budget impact analysis of revumenib for the treatment of relapsed or refractory acute leukemias with a <i>KMT2A</i> translocation in the United StatesIvo Abraham, Pam Martin, Shailja Vaghela, et al.
Journal of General Internal Medicine|November 25, 2024
National Survey of Factors Associated with Physician Antibiotic Prescribing PreferencesDongzhe Hong, Aaron S Kesselheim, Robert Morlock, et al.
Open Forum Infectious Diseases|January 22, 2026
Physician Antibiotic Prescribing Preferences in Community Acquired Pneumonia and Complicated Urinary Tract Infections: A National Discrete Choice ExperimentDongzhe Hong, Aaron S Kesselheim, Joshua P Metlay, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 16, 2014
Development and evaluation of a measure to assess restorative sleepChristopher L Drake, Ron D Hays, Robert Morlock, et al.
Advances in Therapy|May 28, 2016
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective AnalysisFredrik Nyberg, Laura Horne, Robert Morlock, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
American Journal of Ophthalmology|March 26, 2017
Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and ValidationRobert Morlock, R J Wirth, Steven R Tally, et al.
CNS Neuroscience & Therapeutics|February 21, 2009
Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorderDouglas E Feltner, Jane Harness, Jerri Brock, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 10, 2018
Scale development with small samples: a new application of longitudinal item response theoryCarrie R Houts, Robert Morlock, Steven I Blum, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 23, 2021
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinomaFlorian Lordick, Salah-Eddin Al-Batran, Arijit Ganguli, et al.
Cancer Management and Research|May 12, 2017
Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experimentJuan Marcos González, Sarika Ogale, Robert Morlock, et al.
Journal of Managed Care & Specialty Pharmacy|June 3, 2025
Budget impact analysis of revumenib for the treatment of relapsed or refractory acute leukemias with a <i>KMT2A</i> translocation in the United StatesIvo Abraham, Pam Martin, Shailja Vaghela, et al.
Journal of General Internal Medicine|November 25, 2024
National Survey of Factors Associated with Physician Antibiotic Prescribing PreferencesDongzhe Hong, Aaron S Kesselheim, Robert Morlock, et al.
Open Forum Infectious Diseases|January 22, 2026
Physician Antibiotic Prescribing Preferences in Community Acquired Pneumonia and Complicated Urinary Tract Infections: A National Discrete Choice ExperimentDongzhe Hong, Aaron S Kesselheim, Joshua P Metlay, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 16, 2014
Development and evaluation of a measure to assess restorative sleepChristopher L Drake, Ron D Hays, Robert Morlock, et al.
Advances in Therapy|May 28, 2016
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective AnalysisFredrik Nyberg, Laura Horne, Robert Morlock, et al.
Pageof 5